Dimensional Fund Advisors LP Purchases 488 Shares of Innospec Inc. (NASDAQ:IOSP)

Dimensional Fund Advisors LP increased its position in Innospec Inc. (NASDAQ:IOSP – Get Rating) by 0.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,197,700 shares of the specialty chemicals company’s stock after purchasing an additional 488 shares during the period. Dimensional Fund Advisors LP owned approximately 4.84% of Innospec worth $123,197,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of IOSP. CWM LLC lifted its stake in Innospec by 49.2% during the 4th quarter. CWM LLC now owns 294 shares of the specialty chemicals company’s stock valued at $30,000 after acquiring an additional 97 shares during the period. Parallel Advisors LLC bought a new position in Innospec during the 4th quarter valued at about $33,000. Quadrant Capital Group LLC lifted its stake in Innospec by 557.5% during the 3rd quarter. Quadrant Capital Group LLC now owns 526 shares of the specialty chemicals company’s stock valued at $45,000 after acquiring an additional 446 shares during the period. Captrust Financial Advisors lifted its stake in Innospec by 74.7% during the 1st quarter. Captrust Financial Advisors now owns 498 shares of the specialty chemicals company’s stock valued at $46,000 after acquiring an additional 213 shares during the period. Finally, Point72 Hong Kong Ltd bought a new position in Innospec during the 3rd quarter valued at about $48,000. Institutional investors own 94.97% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Innospec in a research note on Thursday. They set a “buy” rating on the stock.

Innospec Stock Up 0.6 %

NASDAQ IOSP opened at $98.70 on Friday. Innospec Inc. has a 52 week low of $83.13 and a 52 week high of $116.00. The firm has a market capitalization of $2.45 billion, a P/E ratio of 19.02 and a beta of 1.17. The company has a 50-day moving average price of $101.42 and a 200-day moving average price of $105.91.

Innospec (NASDAQ:IOSP – Get Rating) last released its quarterly earnings results on Wednesday, May 3rd. The specialty chemicals company reported $1.38 EPS for the quarter, beating the consensus estimate of $1.19 by $0.19. The firm had revenue of $509.60 million during the quarter, compared to analyst estimates of $496.47 million. Innospec had a net margin of 6.48% and a return on equity of 13.77%. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.53 EPS. As a group, equities research analysts anticipate that Innospec Inc. will post 6.02 EPS for the current year.

Innospec Increases Dividend

The company also recently announced a Semi-Annual dividend, which will be paid on Wednesday, May 31st. Investors of record on Monday, May 22nd will be issued a $0.69 dividend. This represents a yield of 1.3%. This is a positive change from Innospec’s previous Semi-Annual dividend of $0.65. The ex-dividend date is Friday, May 19th. Innospec’s dividend payout ratio is currently 25.05%.

Insider Buying and Selling

In other news, Director Leslie J. Parrette bought 515 shares of Innospec stock in a transaction that occurred on Wednesday, May 10th. The stock was bought at an average cost of $96.75 per share, with a total value of $49,826.25. Following the acquisition, the director now owns 3,210 shares of the company’s stock, valued at approximately $310,567.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Patrick Williams sold 9,146 shares of Innospec stock in a transaction that occurred on Friday, February 24th. The shares were sold at an average price of $108.50, for a total transaction of $992,341.00. Following the sale, the chief executive officer now owns 183,479 shares in the company, valued at $19,907,471.50. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Leslie J. Parrette acquired 515 shares of Innospec stock in a transaction dated Wednesday, May 10th. The shares were bought at an average price of $96.75 per share, for a total transaction of $49,826.25. Following the transaction, the director now owns 3,210 shares of the company’s stock, valued at $310,567.50. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 3,074 shares of company stock valued at $322,356 and sold 51,444 shares valued at $5,586,546. 1.52% of the stock is currently owned by insiders.

About Innospec

(Get Rating)

Innospec, Inc develops, manufactures, blends, markets and supplies fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels.